Перевести на Переведено сервисом «Яндекс.Перевод»

Pernix Therapeutics Holdings

Country
USA
Краткое название
Pernix Therapeutics Holdings
Headquarters
10003 Woodloch Forest Drive
Members of the board

Cooper C. Collins,
President and Chief Executive Officer
David Becker,
Chief Financial Officer
Michael Venters,
Vice President of Corporate Development
Tracy S. Clifford,
Corporate Controller and Director of Finance
Beth Bonner DeVille,
Vice President of Sales Training & Compliance
Joseph T. Schepers,
Director of Investor Relations and Corporate Communications
Robert H. Cline, Jr.,
Pharm D., Vice President of Supply Chain Management
Shawn M. Dol,
National Sales Director, Pediatric Division
Brandon R. Belanger,
National Sales Director, Gastroenterology Division
Jamison V. Roberts,
Director of Government Affairs
Leslie White,
Director of Regulatory Affairs & Quality Assurance

Categories medicine
Infantile diseases (Pediatrics)
Stage of the project
Production
Disease
Respiratory diseases, Fever & hyperthermia
Ticker
PTX
Current owners

Michael C. Pearce,
Chairman of the Board of Directors
Cooper C. Collins,
Anthem Hayek Blanchard
James E. Smith, Jr.,
Steven A. Elms

Assets
230.7600
Technology
Other, Pharmaceuticals, Chemistry